Repeated administration of autologous tumor-infiltrating lymphocytes (LM103 infusion) alongside immune checkpoint inhibitors results in sustained tumor regression in a patient with advanced mucosal melanoma: a case study and review of existing literature - Top-Institutions - MDSpire

Repeated administration of autologous tumor-infiltrating lymphocytes (LM103 infusion) alongside immune checkpoint inhibitors results in sustained tumor regression in a patient with advanced mucosal melanoma: a case study and review of existing literature

  • By

  • Fenge Li

  • Yue Xu

  • Yupeng Wang

  • Ning Mu

  • Mei Liu

  • Weihong Feng

  • Yongming Xue

  • Shengnan Wu

  • Xinyi Wang

  • Gregory Lizee

  • Chunhua Ma

  • April 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute (NCI), Center for Cancer Research
    National Cancer Institute (NCI), Center for Cancer Research

    Bethesda, MD

    Key Differentiators

    • Immuno-oncology
    • Adoptive Cell Therapy
    • Melanoma

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Immunotherapy
    • Melanoma
    • Cellular Therapy

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Immuno-oncology
    • Melanoma
    • Adoptive Cell Therapy

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Immunotherapy
    • Melanoma
    • Cellular Therapy

  • #5

    City of Hope National Medical Center
    City of Hope National Medical Center

    Duarte, CA

    Key Differentiators

    • Adoptive Cell Therapy
    • Immuno-oncology
    • Melanoma

Original Source(s)

Repeated administration of autologous tumor-infiltrating lymphocytes (LM103 infusion) alongside immune checkpoint inhibitors results in sustained tumor regression in a patient with advanced mucosal melanoma: a case study and review of existing literature

  • by Fenge Li, Yue Xu, Yupeng Wang, Ning Mu, Mei Liu, Weihong Feng, Yongming Xue, Shengnan Wu, Xinyi Wang, Gregory Lizee, Chunhua Ma

  • April 23, 2026

Related Content

Primary amelanotic leptomeningeal melanocytosis mimicking subarachnoid hemorrhage: a case report of the deceptive masquerader

2025 San Antonio Breast Cancer Symposium Recap

Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

  • 1 min
Ferroptosis, Pyroptosis, and Necroptosis in Melanoma: Regulatory Cell Death Pathways and Their Implications for Immunotherapy